Inclisiran, an siRNA therapy, significantly reduces LDL-C by 28.5% in adolescents with heterozygous familial hypercholesterolemia (HeFH).

HealthDay News — COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia (PE), according to a study published online Feb. 18 in eClinicalMedicine.

FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.

Exercise for osteoarthritis has a negligible or short-lasting effect on pain and function, according to a review.

Pregnancy and breastfeeding are associated with stronger long-term cognitive ability among postmenopausal women.

Three-month romosozumab followed by denosumab is noninferior to a 12-month course for total hip BMD gains in postmenopausal osteoporosis.

People with type 2 diabetes starting semaglutide have more than a doubled risk for NAION versus those starting SGLT2is.

After more than a month on the picket line, thousands of nurses at NewYork-Presbyterian hospitals have voted to end their strike.

Tirzepatide use is associated with a lower incidence of new or progressive diabetic retinopathy (DR) and fewer complications.

Transgender/gender diverse (TGD) individuals with vs without PCOS experience similar cardiometabolic changes on testosterone therapy.

HealthDay News — Ultra-endurance running accelerates red blood cell (RBC) aging through inflammatory and oxidative pathways, according to a study published online Feb. 18 in Blood Red Cells & Iron.

Steatotic liver disease (SLD) in pregnancy is associated with increased odds of hypertensive disorders of pregnancy (HDP).